Stay updated with breaking news from Sam Eiber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medical device giant Boston Scientific added to its string of recent acquisitions by announcing its plan to buy Axonics, a maker of neurostimulation devices that treat urinary and bowel dysfunction, for $3.7 billion. Experts agree that this deal will make a profitable impact on Boston Scientific’s urology business.
Boston Scientific announced today that it agreed to acquire Axonics in a deal worth approximately $3.7 billion.
The FDA today published a 510(k) premarket notification granting clearance to the Stork baby monitoring system from Masimo.
Apple reportedly paused sales of two models of its smartwatches in the U.S. as it looks to resolve a patent dispute with Masimo.
BTIG analysts say a small survey of surgeons may indicate an oversell of AtriCure stock following Medtronic's launch of a competing device.